APA (7th ed.) Citation

KE, D., K, W., HJ, L., E, S., & R, R. (1996). Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 28(9), 419. https://doi.org/10.1055/s-2007-979830

Chicago Style (17th ed.) Citation

KE, Draeger, Wernicke-Panten K, Lomp HJ, Schüler E, and Rosskamp R. "Long-term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl): A Double-blind Comparison with Glibenclamide." Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme 28, no. 9 (1996): 419. https://doi.org/10.1055/s-2007-979830.

MLA (9th ed.) Citation

KE, Draeger, et al. "Long-term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl): A Double-blind Comparison with Glibenclamide." Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, vol. 28, no. 9, 1996, p. 419, https://doi.org/10.1055/s-2007-979830.